Pacibekitug is under clinical development by Tourmaline Bio and currently in Phase II for Graves' Ophthalmopathy.

Tourmaline Oil Corp. closed C$5.34 short of its 52-week high of C$69.25, which the company reached on May 23rd.

Barclays PLC increased its position in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 283.7% in the 3rd ...

Shares of Tourmaline Oil Corp. TOU advanced 4.51% to C$66.79 Monday, in what proved to be an otherwise all-around negative trading session for the Canadian market, with the S&P/TSX Composite Index ...

Tourmaline is Canada’s largest natural gas producer and fourth largest midstream operator with an expansive production base ...

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report)’s share price was down 3.9% during mid-day trading on Tuesday . The company traded as low as $20.02 and last traded at $20.46. Approximately 15,772 ...

Achieving full cycle profitability and efficiencies has allowed this energy stock to become a top dividend stock. The post ...

Tourmaline Oil remains fairly valued despite recent underperformance and steady oil and gas prices; investors should wait for a more attractive entry point. TRMLF boasts strong business momentum ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

You can sit under it while you get other things done, like checking emails or even just scrolling,” said TikToker Seth ...